Access cutting-edge prostate cancer treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This phase II trial studies how well atezolizumab works alone or in combination with etrumadenant or tocilizumab in treating men with localized prostate cancer before radical prostatectomy. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Androgens can cause the growth of prostate cancer cells. IL-6 is expressed by prostate cancer and within the tumor microenv
Sponsor: David Oh
Check if you qualify for this prostate cancer clinical trial in St Louis, MO
If you're searching for prostate cancer treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.